Bedrosian Camille L Insider Trades

Insider Trading History

Track insider trading activity for Bedrosian Camille L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.86M 22,225 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.90
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $4.72M 265,285 shares
Last Trade
Mar 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.38M 239,975 shares
$14.10
$17.78
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $3.01M 169,295 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$94.2k 6,461 shares
$14.58
$17.78
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $3.12M 175,756 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$94.4k 6,580 shares
$14.35
$17.78
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $3.24M 182,336 shares
Last Trade
Sep 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$176k 12,039 shares
$14.58
$17.78
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $772k 7,037 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$448k 7,037 shares
$63.66
$109.69
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $0 0 shares
Last Trade
Jun 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 4,000 shares
$61.48
$109.69
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $768k 7,000 shares
Last Trade
Jun 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 4,000 shares
$61.48
$109.69
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.37M 16,300 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$83.90
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $3.46M 194,375 shares
Last Trade
Mar 31, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$43.1k 12,425 shares
$3.47
$17.78
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $3.68M 206,800 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 102,630 shares
$3.61
$17.78
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $2.46M 138,380 shares
Last Trade
Dec 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$30k 5,421 shares
$5.54
$17.78
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $2.56M 143,801 shares
Last Trade
Sep 30, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$36.6k 11,442 shares
$3.20
$17.78
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $0 0 shares
Last Trade
Jun 21, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 3,000 shares
$41.87
$109.69
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $329k 3,000 shares
Last Trade
Jun 21, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 3,000 shares
$41.87
$109.69
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $1.54M 14,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$579k 14,000 shares
$41.39
$109.69
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.05M 12,500 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 12,500 shares
$44.71
$83.90
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $2.76M 155,243 shares
Last Trade
Apr 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 120,000 shares
$2.01
$17.78
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Medical Officer
Holding Value $2.89M 162,500 shares
Last Trade
Nov 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.1M 162,500 shares
$12.93
$17.78
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $1.54M 14,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$314k 17,000 shares
$18.47
$109.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up